NCT05837871 Genetic and Haematological Modifiers of SCD Severity in Kaduna State, Northern Nigeria Status UNKNOWN Phase N/A
NCT05833022 Patient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell Centers Status COMPLETED Phase N/A
NCT05810181 Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX) Status RECRUITING Phase N/A
NCT05791591 Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients Status COMPLETED Phase NA
NCT05789355 Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD) Status COMPLETED Phase NA
NCT05777993 A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study Status ENROLLING_BY_INVITATION Phase PHASE4
NCT05758766 Study on Use of Omega-3 Fatty Acids to Improve Outcomes in Individuals With Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase NA
NCT05748717 Arterial Function Parameters and Transcranial Doppler Velocity in Paediatric Patients With Sickle Cell Disease Status RECRUITING Phase N/A
NCT05736419 A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) Status RECRUITING Phase PHASE2
NCT05730205 Effects of the Contraceptive Implant in Women With Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05725902 Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT05714098 Gerofit Exercise Intervention for Older Adults With Sickle Cell Disease (SICKLE-FIT Study) Status COMPLETED Phase NA
NCT05662098 Alternative Dosing And Prevention of Transfusions (ADAPT) Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05649280 Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease Patients Status COMPLETED Phase N/A